- Tempus has entered into agreements with Pathos for $192.5 million in cash payments over approximately five years. The deal significantly strengthens predictable data licensing revenue in oncology and
?? Positive AI Sentiment (+6.8 / 10)
Observed market reaction after signal
4h +3.82% · 24h +5.96% · Peak +3.82%